Carnegie Investment Counsel Buys 1,193 Shares of Bristol-Myers Squibb (NYSE:BMY)

Carnegie Investment Counsel raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 33,435 shares of the biopharmaceutical company’s stock after acquiring an additional 1,193 shares during the quarter. Carnegie Investment Counsel’s holdings in Bristol-Myers Squibb were worth $1,891,000 as of its most […]

Leave a Reply

Your email address will not be published.

Previous post Ritholtz Wealth Management Lowers Position in Johnson & Johnson (NYSE:JNJ)
Next post Coca-Cola Consolidated, Inc. (NASDAQ:COKE) Shares Sold by Ritholtz Wealth Management